Additional file 2: of The value of maintaining normokalaemia and enabling RAASi therapy in chronic kidney disease

Table S1. Summary of methods employed to model disease progression and events in CKD patients. Table S2. Inputs applied to modelled health states and events. (DOCX 37 kb)